MYGN Financial Facts
See Full Income StatementDeferred revenue: 3.03M
Equipment: 62.83M
See Full Balance Sheet
Earnings History for Myriad Genetics Inc. (MYGN)
|
Expand Research on MYGN
| Next EPS Date | 5/2/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +9.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.8% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/5/13 |
Q213 | $0.42 | $0.38 | +$0.04 | $149.1M | $143.71M | N/A / N/A | = | +21.3% | Details | |
| 11/5/12 |
Q113 | $0.36 | $0.32 | +$0.04 | $133.44M | $129.43M | N/A / N/A | = | +22.6% | Details | |
| 5/7/13 |
Q113 | $0.46 | $0.40 | +$0.06 | $156.5M | $148.25M | N/A / N/A | = | +16.4% | Details | |
| 1/31/12 |
Q212 | $0.33 | $0.31 | +$0.02 | $122.8M | $115.28M | N/A / N/A | = | +39.2% | Details | |
| 8/14/12 |
Q212 | $0.34 | $0.34 | $0.00 | $133M | $131.85M | N/A / N/A | = | +29.3% | Details | |
| 11/1/11 |
Q112 | $0.29 | $0.28 | +$0.01 | $110.5M | $106.49M | N/A / N/A | = | +62% | Details | |
| 5/1/12 |
Q112 | $0.34 | $0.32 | +$0.02 | $129.8M | $119.2M | N/A / N/A | = | +26.6% | Details | |
| 8/9/11 |
Q411 | $0.30 | $0.29 | +$0.01 | $107.4M | $104.43M | N/A / N/A | = | +74.2% | Details |

